Ingevity Corporation (NGVT) is a Chemicals - Specialty company in the Basic Materials sector, currently trading at $76.56. It has a SharesGrow Score of 40/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of NGVT = $282.54 (+269% from the current price, the stock appears undervalued). Analyst consensus target is NGVT = $77 (+0.1% upside).
Valuation: NGVT trades at a trailing Price-to-Earnings (P/E) of -15.7 (S&P 500 average ~25).
Financials: revenue is $1.2B, -10.8%/yr average growth. Net income is $167M (loss), growing at -2636.6%/yr. Net profit margin is -14.3% (negative). Gross margin is 39.5% (+7.1 pp trend).
Balance sheet: total debt is $1.2B against $30M equity (Debt-to-Equity (D/E) ratio 41.84, leveraged). Current ratio is 1.15 (adequate). Debt-to-assets is 75.3%. Total assets: $1.7B.
Analyst outlook: 10 / 13 analysts rate NGVT as buy (77%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 72/100 (Pass), Growth 15/100 (Fail), Past 25/100 (Fail), Health 33/100 (Fail), Moat 60/100 (Partial), Future 67/100 (Pass), Income 10/100 (Fail).
